Horizon Discovery (North America) Inc.
GPTKB entity
Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_PerkinElmer
|
| gptkbp:awards |
Top 100 Companies
Best Company to Work For Excellence in Innovation Innovative_Company_Award |
| gptkbp:customerBase |
Academic institutions
Research organizations Pharmaceutical companies Biotech_companies |
| gptkbp:employees |
200+
|
| gptkbp:focus |
Precision medicine
Therapeutic development Genomic research Biomarker_discovery |
| gptkbp:founded |
2007
|
| gptkbp:headquarters |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Horizon Discovery (North America) Inc.
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:keyPeople |
gptkb:Dr._David_A._H._Smith
gptkb:Darrin_M._Disley gptkb:Dr._David_E._H._Smith |
| gptkbp:location |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:mission |
To enable scientists to accelerate their research.
|
| gptkbp:partnerships |
Research institutions
Pharmaceutical companies University collaborations |
| gptkbp:products |
CRISPR technology
RNAi technology Cell line engineering Gene knockout services |
| gptkbp:revenue |
$50 million (2020)
|
| gptkbp:services |
Genetic engineering
Cell line development Gene_editing |
| gptkbp:subsidiary |
gptkb:Horizon_Discovery_Ltd.
gptkb:Horizon_Discovery_(Asia)_Ltd. gptkb:Horizon_Discovery_(Europe)_Ltd. gptkb:Horizon_Discovery_(UK)_Ltd. |
| gptkbp:technology |
gptkb:CRISPR/Cas9_technology
RNA interference technology Cell line engineering technology Gene_editing_technology |
| gptkbp:values |
Collaboration
Innovation Integrity Customer focus |
| gptkbp:vision |
To be the leading provider of gene editing solutions.
|
| gptkbp:website |
www.horizondiscovery.com
|